Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Suzan Alhassanin"'
Publikováno v:
Middle East Current Psychiatry, Vol 27, Iss 1, Pp 1-7 (2020)
Background The oncologists are facing more challenges than ever before in their work with cancer patients. The aim of the study is to assess the level of work-related stress among oncology clinicians and to compare it with non-oncologists. Thirty onc
Autor:
Amira I. Aldesoky, Suzy F. Gohar, Asmaa M. Elbrolosy, Shaimaa S. Solimani, Suzan Alhassanin, Eman H. Salem, Samah M. Awad
Publikováno v:
Microbiology Research Journal International. :1-10
Background: Invasive aspergillosis (IA) is a leading cause of death among immunocompromised patients, particularly those with hematological malignancies. The use of galactomannan (GM) antigen as a biological marker for screening of IA in high-risk pa
Publikováno v:
Medical Oncology. 38
The development of drug resistance remains the major obstacle to clinical efficacy of cancer chemotherapy. Consequently, finding new therapeutic options for cancerous patients is an urgent need. Sixty newly diagnosed diffuse large B-cell lymphoma (DL
Autor:
Suzy F. Gohar, M. S. Elnaggar, Shaimaa Soliman, W. A. ElSherief, Suzan Alhassanin, Mohamed R. Soltan
Publikováno v:
Middle East Current Psychiatry, Vol 27, Iss 1, Pp 1-6 (2020)
BackgroundCancer-care health professionals are at great risk of workplace stress and high burnout levels. Only a few studies were studying the prevalence of workplace stress and burnout in medical oncologists in Egypt. The aim of the work is to study
Autor:
Khaled Abd El Aziz, Naser Abd El Bary, Suzy F. Gohar, Mohamed A Shehata, Amira H Hegazy, Suzan Alhassanin
Publikováno v:
International Journal of Cancer and Biomedical Research.
Background: Understanding the molecular basis of lung cancer has led to the development of targeted agents with a significant clinical benefit. This benefit is confined to patients with specific molecular tumor characteristics. However, chemotherapy
Publikováno v:
Research in Oncology, Vol 14, Iss 2, Pp 70-74 (2018)
Background: The immune marker neopterin may have a prognostic role in different cancers including breast cancer. Aim: To assess the relation between pre-chemotherapy serum level of neopterin and the clinical and pathological features of breast cancer
Publikováno v:
Immunological Investigations. 47:315-325
Non-Hodgkin lymphoma (NHL) is a major cancer in Egypt and worldwide and has many risk factors including genes involved in the immune response.we investigated the HLA-G 14bp gene polymorphism as a risk factor for NHL and its clinic pathologic features
Publikováno v:
Journal of Cancer Science & Therapy. 10
Publikováno v:
Research in Oncology. 10:40-45
Autor:
K. Abd El Aziz, Suzy F. Gohar, Suzan Alhassanin, Amira H Hegazy, Mohamed A Shehata, N. Abd El Bary
Publikováno v:
Annals of Oncology. 30:ix172
Background Maintenance therapy is one strategy that has been investigated as a way of improving outcomes in patients with non-small cell lung cancer. This study was conducted to evaluate the effect of weekly paclitaxel as a continuation maintenance t